As of Jun 28
| +0.0174 / +4.73%|
The 1 analysts offering 12-month price forecasts for Interpace Diagnostics Group Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +678.41% increase from the last price of 0.39.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.